| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(1.40) per share. This is a 87.93 percent increase over losses of $(...
																	
																	
																	
																	
																	
																	U.S. stock futures declined on Monday after a holiday-shortened week that ended with a mixed close on Thursday.